FDA Inspection 629866 — New York Blood Center Enterprises
The FDA completed an inspection of New York Blood Center Enterprises on November 24, 2009 in Rockville Centre, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 24, 2009
- Fiscal Year
- 2010
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rockville Centre, NY (United States)